125276-72-4 Usage
Uses
Used in Pharmaceutical Industry:
(1aS,2S,3R,13cR)-1a,2,3,13c-tetrahydrobenzo[h][1]benzoxireno[2,3-a]acridine-2,3-diol is used as a potential drug candidate for further research and development. Its unique chemical structure and stereochemistry may contribute to its potential pharmacological properties, making it a promising candidate for various applications in the pharmaceutical industry. Further studies may be necessary to fully understand its biological and medicinal potential and to explore its potential uses in treating various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 125276-72-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,5,2,7 and 6 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 125276-72:
(8*1)+(7*2)+(6*5)+(5*2)+(4*7)+(3*6)+(2*7)+(1*2)=124
124 % 10 = 4
So 125276-72-4 is a valid CAS Registry Number.
125276-72-4Relevant articles and documents
Synthesis of Dihydrodiols and Diol Epoxides of Dibenzacridine
Kumar, Subodh,Agarwal, Nand L.
, p. 2445 - 2449 (2007/10/02)
trans-1,2-Dihydroxy-1,2-dihydrodibenzacridine (5), trans-3,4-dihydroxy-3,4-dihydrodibenzacridine (6), trans-8,9-dihydroxy-8,9-dihydrodibenzacridine (7), 3α,4β-dihydroxy-1α,2α-epoxy-1,2,3,4-tetrahydrodibenzacridine (9), and 3α,4β-dihydroxy-1β,2β-epoxy-1,2,3,4-tetrahydrodibenzacridine (10), which are potentially proximate and ultimate carcinogens of dibenzacridine (1), are synthesized from a common intermediate 8,9,10,11-tetrahydrodibenzacridine (13).The Birch reduction of 13 produced an intermediate which has been used in preparing 5 and 6.However, the bromination of 13 followed by dehydrobromination resulted in a mixture of isomeric alkenes which was successfully converted to 7. 1H NMR, UV, and mass spectra of dibenzacridine derivatives are reported.
